Search the Newsreel

Millrose Properties Inc (MRP) Q2 2026 Earnings Report Preview: What To Look For

Melrose Industries (LON:MRO) Receives Outperform Rating from Royal Bank Of Canada

Euroseas Stock Price Forecast. Should You Buy ESEA?

Euroseas Ltd. (ESEA) stock saw a -2.43% drop on August 5, 2026, marking its fourth consecutive daily fall. Despite this, StockInvest.us maintains a "Hold/Accumulate" rating with a technical score of -0.50, forecasting a 9.01% rise over the next three months. The company has strong …

Equus Total Return, Inc. Revenue Breakdown – BOATS:EQS

This article provides a revenue breakdown for Equus Total Return, Inc. (EQS), highlighting the company's financial performance by segment and country. The United States is identified as the largest contributor to revenue, with figures for the last year and the year before. The data …

Sei Investments Co. Has $9.72 Million Holdings in Millrose Properties, Inc. $MRP

Equus Total Return (EQS) Holds Flat at $1.16 as Range-Bound Trading Persists - Swing Entry Signals

25,200 Shares in Goosehead Insurance $GSHD Bought by Healthcare of Ontario Pension Plan Trust Fund

Suzano Holding SA Revenue Breakdown – BMFBOVESPA:NEMO3

This article provides a revenue breakdown for Suzano Holding SA (NEMO3). It highlights that Asia was the greatest contributor to the company's revenue, generating 18.03 billion BRL last year and 15.79 billion BRL the year prior. The report focuses on segmental and regional financial …

Canada Goose: Off-Season Resilience Meets Valuation Floor; Reiterate Neutral (NYSE:GOOS)

Millrose Properties, Inc. Revenue Breakdown – NYSE:MRP

Price to sales forward of Suzano S.A. – BMFBOVESPA:SUZB3

The article focuses on the "Price to sales forward" financial metric for Suzano S.A. (BMFBOVESPA:SUZB3) as presented on TradingView. It indicates that the market for SUZB3 is currently closed with no trades. The content primarily showcases the navigation and various features available on the …

Canada Goose (TSX:GOOS) Stock Grapples With Inventory Risk And Valuation Gap

Suzano Papel e Celulose SA (SUZ) Q4 2024 Earnings Report - Results, Call & Slides

Suzano Papel e Celulose SA (SUZ) reported its Q4 2024 earnings, missing EPS estimates but exceeding revenue expectations. The company posted an actual EPS of -$0.93 against a consensus of -$0.78, while actual revenue reached $2.43 billion, beating the expected $2.18 billion with a …

Millrose Properties (MRP) Stock Looks Undervalued Despite Its 6% YTD Slide

NeuroSense Therapeutics (NRSN) seeks reverse split amid Nasdaq compliance push

NeuroSense Therapeutics (NRSN) is calling a Special Meeting of Shareholders on August 26, 2026, to seek approval for a reverse stock split. This move is aimed at regaining compliance with Nasdaq's minimum bid price ($1.00) and market value of listed securities ($35 million) requirements, …

NeuroSense Therapeutics (NRSN) revises Capital on Demand share sales deal

NeuroSense Therapeutics has amended its Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC, updating the referenced registration statement to a new Form F-3 (File No. 333-293060), which became effective on July 31, 2026. Under the revised agreement, the company can offer and …

Melrose Industries PLC (MLSPF) (H1 2026) Earnings Call Highlights: Garden Grove Impact and ...

This article first appeared on GuruFocus. Release Date: July 31, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Q & A Highlights Q: What is the financial impact of the Garden Grove incident, and what …

Goosehead Insurance (GSHD) director purchases 1,600 shares in open-market trade

Goosehead Insurance, Inc. director Peter R. Lane purchased 1,600 shares of Class A Common Stock on July 31, 2026, at $63.14 per share in an open-market transaction. Following this purchase, he directly holds 1,600 shares. The filing specifies that this trade was not made …

Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook

Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook Proactive uses images sourced from Shutterstock Melrose Industries PLC (LSE:MRO, OTC:MLSPF) shares fell 3.5% to 458.8p after the aerospace and defence group warned of further exceptional costs linked to a chemical …

Close Brothers names new chair as Mike Biggs steps down By Investing.com

Euroseas Ltd (ESEA) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Euroseas Ltd (ESEA), detailing its current risk score, beta value, and various volatility and financial risk metrics. The company's risk assessment score is 5.40, ranking 37th in the Freight & Logistics Services industry, with a beta of …

Canada Goose (NYSE:GOOS) Issues Quarterly Earnings Results

Canada Goose Holdings Inc. 2027 Q1 - Results - Earnings Call Presentation (TSX:GOOS:CA) 2026-07-31

Melrose Industries PLC 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:MLSPF) 2026-07-31

Melrose Industries (MRO) Posts 10% Revenue Increase in H1 2026 but Halts £175m Share Buyback Following Garden Grove Chemical Incident

Are BAE Systems (LSE:BA.) And Melrose Industries (LSE:MRO) Showing Why Industrial Stocks Matter In Today's UK Market?

Euroseas Ltd (ESEA) Institutional Confidence

The article analyzes Euroseas Ltd's (ESEA) institutional confidence score, which is currently 3.00, placing it 37th in the Freight & Logistics Services industry. Institutional shareholding increased by 26.63% quarter-over-quarter, with James Simons noted as the largest individual institutional shareholder. The report also lists top …

SUZ|Suzano SA|Price:8.495|Chg%:+0.055

This article provides a comprehensive stock analysis of Suzano SA (SUZ), highlighting its healthy fundamentals, high growth potential, and relatively fair valuation within the Paper & Forest Products industry. It notes strong institutional ownership, recent "Buy" ratings from analysts, and a stable stock price …

NeuroSense Therapeutics Ltd. Revenue Breakdown – NASDAQ:NRSNW

This article provides a brief overview of NeuroSense Therapeutics Ltd. (NASDAQ: NRSNW) financial information. It indicates that the market was closed at the time of viewing and that no trades were made, with details on financial statements, dividends, earnings, and segments available for further …

Adrienne Kebodeaux sells 5,000 Goosehead Insurance common shares for $326,000

Adrienne Kebodeaux, a 10% owner of Goosehead Insurance, sold 5,000 Class A shares for $65.2 each, totaling $326,000, on July 28, 2026. This transaction followed a conversion of 5,000 Class B shares to Class A, leaving her with no direct Class A holdings but …

Goosehead Insurance 10% owner trust sells $8.88m in shares

The Mark & Robyn Jones Descendants Trust 2014, a 10% owner of Goosehead Insurance (NASDAQ:GSHD), sold approximately $8.88 million worth of Class A Common Stock across July 29 and 30, 2026. These sales occurred after converting Class B Common Stock and LLC Units into …

Form 4 Goosehead Insurance Inc For: 30 July By Investing.com

This article reports on a Form 4 filing for Goosehead Insurance Inc. for July 30, as released by Investing.com. A Form 4 is a document required by the U.S. Securities and Exchange Commission (SEC) to be filed by company insiders when they buy or …

Adrienne Kebodeaux (GSHD) converts LLC units and sells 5,000 Class A shares

Adrienne Kebodeaux, a 10% owner of Goosehead Insurance (GSHD), converted 5,000 LLC Units and Class B Common Stock into 5,000 Class A Common Stock shares on July 28, 2026. She subsequently sold these 5,000 Class A shares at a weighted average price of $65.20 …

Goosehead Insurance (GSHD) trust converts units, sells 5,000 Class A shares

The Chick & The Bear Irrevocable Trust and Adrienne Kebodeaux, part of a 10% owner group of Goosehead Insurance (GSHD), converted 5,000 LLC Units and Class B shares into 5,000 Class A Common Stock shares. Subsequently, they sold these 5,000 Class A shares at …

NeuroSense Therapeutics (NRSN) sets $150M shelf and $3.8M ATM share plan

NeuroSense Therapeutics has filed a shelf registration to offer up to $150 million in various securities and a related at-the-market (ATM) program for up to $3.8 million in ordinary shares. The company, focused on neurodegenerative diseases like ALS, reported positive Phase 2b data for …

Canada Goose Beats Revenue Estimates as Demand Holds Up